Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation
Nj. Hallab et al., Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation, MOL C BIOCH, 222(1-2), 2001, pp. 127-136
Metal toxicity from sources such as orthopaedic implants was investigated i
n terms of immune system hyper-reactivity to metal implant alloy degradatio
n products. Lymphocyte response to serum protein complexed with metal from
implant alloy degradation was investigated in this in vitro study using pri
mary human lymphocytes from healthy volunteers (n = 10). Cobalt chromium mo
lybdenum alloy (Co-Cr-Mo, ASTM F-75) and titanium alloy (Ti-6Al-4V, ASTM F-
136) beads (70 mum) were incubated in agitated human serum at 37 degrees Ce
lsius to simulate naturally occurring metal implant alloy degradation proce
sses. Particulate free serum samples, which were incubated with metal, were
then separated into molecular weight based fractions. The amounts of solub
le Cr and Ti within each serum fraction were measured and correlated with l
ymphocyte proliferation response to the individual serum fractions. Lymphoc
ytes from each subject were cultured with 11 autologous molecular weight ba
sed serum fractions either with or without added metal. Two molecular weigh
t ranges of human serum proteins were associated with the binding of Cr and
Ti from Co-Cr-Mo and Ti implant alloy degradation (at < 30 and 180-330 kDa
). High molecular weight serum proteins (approximate to 180 kDa) demonstrat
ed greater lymphocyte reactivity when complexed with metal released from Co
-Cr-Mo alloy and Ti alloy than with low (5-30 kDa) and midrange (30-77 kDa)
serum proteins. When the amount of lymphocyte stimulation was normalized t
o both the moles of metal and the moles of protein within each fraction (Me
tal-Protein Complex Reactivity Index, MPCRI), Cr from Co-Cr-Mo alloy degrad
ation demonstrated approximately 10 fold greater reactivity than Ti in the
higher molecular weight serum proteins (approximate to 180-250 kDa). This i
n vitro study demonstrated a lymphocyte proliferative response to both Co-C
r-Mo and Ti alloy metalloprotein degradation products. This response was gr
eatest when the metals were complexed with high molecular weight proteins,
and with metal-protein complexes formed from Co-Cr-Mo alloy degradation.